[EN] SUBSTITUTED 1,6-NAPHTHYRIDINE INHIBITORS OF CDK5<br/>[FR] INHIBITEURS DE CDK5 DE TYPE 1,6-NAPHTYRIDINE SUBSTITUÉE
申请人:GOLDFINCH BIO INC
公开号:WO2022011274A1
公开(公告)日:2022-01-13
Disclosed are compounds having structural formula I, and related salts and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases and conditions such as kidney disease, kidney failure, kidney stones, or polycystic kidney disease, using the compounds of formula (I), and related salts and pharmaceutical compositions.
揭示了具有结构式I的化合物,以及相关的盐和药物组合物。还揭示了治疗方法,例如利用结构式(I)的化合物、相关盐和药物组合物治疗疾病和病况,如肾病、肾衰竭、肾结石或多囊肾病。